Hetero Biopharma Is A Subsidiary Of The Hetero Groupa Global Pharmaceutical Company Founded In 1993As A Leading Developer Of Biosimilarshetero Biopharma Specializes In Complex Biologic Therapiesaiming To Make Them Affordable And Accessible Worldwideparticularly For Underserved Populationsthe Company Leverages The Expertise Of The Hetero Group In Generic Active Pharmaceutical Ingredientsapisand Antiretroviral Drugs The Company Focuses On Developing Niche And Complex Biosimilarsutilizing Advanced Technology And Regulatory Knowledge To Expedite Product Launchesits Therapeutic Areas Include Oncologyimmunologyand Chronic Disease Treatmentshetero Biopharma Benefits From State Of The Art Manufacturing Facilities Inherited From The Hetero Groupwhich Produces Apisgenericsand Finished Dosageswith A Global Reachthe Company Targets Multinational Pharmaceutical Firms And Health Agenciesadapting Its Business Model To Meet Diverse Regulatory And Clinical Requirements
